Broadly, mice that exhibit Aβ plaque formation via human APP and human PS1, but not pTau neurofibrillary tangles, exhibit varying circadian alterations but do not reliably recapitulate the neurodegeneration nor the specific circadian dysfunction seen in AD patients. This evidence concerns the gene PSEN1 and Alzheimer disease.